New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial
Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too
Rituximab Prolonged Survival Of CLL In Phase III Study
A Low-Cost Vaccine To Enter Clinical Trials In A Year
HPV DNA Testing Reduced Cervical Cancer Precursors
Targeting Men At High Risk Finds More Head & Neck Cancer
Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds
Multivitamin Use Doesn’t Impact Outcomes, Study Finds
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- ACOG says it will no longer accept federal funding
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV
- “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor
